TherapeuticsMD | TXMD - Selling And Administration Expenses


TherapeuticsMD reported $1.23M in Selling and Administration Expenses for its fiscal quarter ending in June of 2024.





Selling And Administration Expenses Change Date
AbbVie USD 3.63B 54M Jun/2026
Alterity Therapeutics Limited AUD 1.45M 703.96K Dec/2025
Cipla INR 13.25B 101.8M Dec/2025
Clal Biotechnology ILS 3.31M 513K Dec/2022
Compugen USD 2.43M 222K Mar/2026
CSL USD 1.23B 498M Dec/2025
Grifols EUR 320.45M 12.65M Dec/2025
Novo Nordisk DKK 2.54B 10.68B Jun/2026
Pfizer USD 3.41B 496M Jun/2026
TherapeuticsMD USD 1.23M 90K Jun/2024